Age-related changes in serum growth hormone, insulin-like growth factor-1 and somatostatin in system lupus erythematosus

BMC Musculoskeletal Disorders

Volumn 5, Issue , 2004, Pages

  Denko, Charles W ^a   Malemud, Charles J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; SOMATOSTATIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENDER; GROWTH HORMONE BLOOD LEVEL; HEALTH STATUS; HUMAN; RADIOIMMUNOASSAY; STANDARDIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGE FACTORS; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; REGRESSION ANALYSIS; SOMATOSTATIN;

EID: 12344307591     PISSN: 14712474     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-5-37     Document Type: Article

References (31)

1. Kammer GM, Perl A, Richardson BC, Tsokos G: Abnormal T cell signal transduction in systemic lupus eythematosus. Arthritis Rheum 2002, 46:1139-1154.
2. Khan IU, Tsokos G, Kammer GM: Abnormal B cell transduction in systemic lupus erythematosus. Curr Dir Autoimmun 2003, 6:89-104.
3. Tan EM: Pathophysiology of antinuclear antibodies in systemic lupus erythematosus and related diseases. Adv Dent Res 1996, 10:44-46.
4. Walport MJ, Davies KA, Morley BJ, Botto M: Complement deficiency and autoimmunity. Ann NY Acad Sci 1997, 815:267-281.
5. Lahita RG: Emerging concepts for sexual predilection in the disease systemic lupus erythematosus. Ann NY Acad Sci 1999, 876:64-69.
6. Pisetsky DS: Systemic lupus erythematosus. A. Epidemiology, pathology and pathogenesis. In In Primer on the Rheumatic Diseases 12th edition. Edited by: Klippel JH. Atlanta: The Arthritis Foundation; 2001:329-335.
7. Lahita GC: System Lupus Erythematosus 3rd edition. San Francisco: Academic Press; 1998.
8. Denko CW, Boja B, Moskowitz RW: Growth promoting peptides in osteoarthritis: Insulin, insulin-like growth factor-1, growth hormone. J Rheumatol 1990, 17:1217-1221.
9. Denko CW, Boja B, Moskowitz RW: Growth factors, insulin-like growth factor-1 and growth hormone in synovial fluid and serum of patients with rheumatic diseases. Osteoarthritis Cartilage 1996, 4:245-249.
10. Denko CW, Boja B: Growth factors in asymptomatic osteoarthritis - insulin, insulin-like growth factor-1, growth hormone. Inflammopharmacology 1993, 2:71-76.
11. Denko CW, Malemud CJ: Metabolic disturbances and synovial fluid responses in osteoarthritis. Front Biosci 1999, 4:d686-d693.
12. Denko CW, Boja B, Moskowitz RW: Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis - insulin, insulin-like growth factor-1, growth hormone. J Rheumatol 1994, 21:1725-1730.
13. Denko CW, Malemud CJ: Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH). Front Biosci 2002, 7:a37-a43.
14. Denko CW, Boja B: Growth hormone, insulin, insulin-like growth factor-1 in hypermobility syndrome. J Rheumatol 2001, 28:1666-1669.
15. Denko CW, Malemud CJ: Serum growth hormone and insulin, but not insulin-like growth factor-1 levels are elevated in patients with fibromyalgia syndrome. Rheumatol Int in press.
16. Denko CW, Boja B, Malemud CJ: Intra-erythrocyte deposition of growth hormone in rheumatic diseases. Rheumatol Int 2003, 23:11-14.
17. Denko CW, Malemud CJ: The serum growth hormone to somatostatin ratio is skewed upward in rheumatoid arthritis patients. Front Biosci 2004, 9:1660-1664.
18. Kreinenkamp HJ: Molecular biology of the receptors for somatostatin and corticostatin. In In Regulatory Peptides and Cognate Receptors Edited by: Richter D. Berlin: Springer-Verlag; 1999:215-237.
19. Marabini S, Matucci-Cerinic M, Gepetti P, Del Bianco E, Marchesoni A, Tosi S, Cagnoni M, Partsch G: Substance P and somatostatin levels in rheumatoid arthritis, osteoarthritis and psoriatic arthritis. Ann NY Acad Sci 1991, 632:435-436.
20. Sakane T, Suzuki N: The role of somatostatin in the pathophysiology of rheumatoid arthritis. Clin Exp Rheumatol 1998, 16:745-749.
21. Buyon JP: Systemic lupus erythematosus. B. Clinical and laboratory features. In In Primer on the Rheumatic Diseases 12th edition. Edited by: Klippel JH. Atlanta: The Arthritis Foundation; 2001:335-346.
22. Ghigo E, Goffi S, Nicolosi M, Arvat E, Valente F, Mazza E, Ghigo MC, Camanni F: Growth hormone responsiveness to combined administration of arginine and growth hormone releasing hormone does not vary with age in man. J Clin Endocrinol Metab 1990, 71:1481-1485.
23. Kelijman M: Age-related alterations of the growth hormone/insulin-like growth factor-1 axis. J Am Geriatr Soc 1991, 39:295-307.
24. Hochberg M, Lethbridge-Cejku M, Scott WW Jr, Reichle R, Plato CC, Tobin JD: Serum levels of insulin-like growth factor-1 in subjects with osteoarthritis of the knee. Data from the Baltimore Longitudinal Study of Aging. Arthritis Rheum 1994, 37:1177-1180.
25. Bennett RM, Cook DM, Clark SR, Burkhardt CS, Campbell SM: Hypothalamic-pituitary-insulin-like growth factor-1 axis dysfunction in patients with fibromyalgia. J Rheumatol 1997, 24:1384-1389.
26. Rovensky J, Jurankova E, Rauova L, Blazickova S, Lukac J, Veselkova Z, Jezova D, Vigas M: Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus. J Rheumatol 1997, 24:2330-2334.
27. Chikanza IC, Kuis W, Keijnen CJ: The influence of hormonal system on pediatric rheumatic diseases. Rheum Dis Clin North Am 2000, 26:911-925.
28. Yap HK, Loke KY, Murugasu B, Lee BW: Subclinical activation of lupus nephritis by recombinant growth hormone. Pediatr Nephrol 1998, 12:133-135.
29. Bae YS, Bae SC, Lee SW, Yoo DH, Kim TY, Kim SY: Lupus flare associated with growth hormone. Lupus 2001, 10:448-450.
30. van Hagen PM: Somatostatin receptor expression in clinical immunology. Metabolism 1996, 45(8 Suppl 1):86-87.
31. Kammer GM, Mishra N: Systemic lupus erythematosus in the elderly. Rheum Dis Clin North Am 2000, 26:475-92.